Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients

NCT03977207 is registered in ClinicalTrials.gov with University of California, Irvine as lead sponsor.

NCT NCT03977207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03977207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients
Lead sponsor
University of California, Irvine
Phase
Not applicable
Overall status
Recruiting
Start date
July 20, 2020
Completion date
November 30, 2025
Enrollment
336 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis, hypothyroidism, thyroid; functional disturbance